A Study of PRT1419 in Patients With Advanced Solid Tumors
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Sarcoma|Melanoma|Lung Cancer|Breast Cancer|Esophageal Cancer|Cervical Cancer|Head and Neck Cancer
Interventions: DRUG: PRT1419
Sponsor: Prelude Therapeutics